Abstract:Despite its well-regarded vector control program, Singapore remains susceptible to dengue epidemics. To assist evaluation of dengue interventions, we aimed to synthesize current data on the epidemiologic and economic burden of dengue in Singapore. We used multiple databases (PubMed, Embase, Cochrane, international/national repositories, surveillance) to search for published and gray literature (2000–2022). We included observational and cost studies, and two interventional studies, reporting Singapore-specific data on our co-primary outcomes, dengue incidence and dengue-related costs. Quality was assessed using the Newcastle-Ottawa Scale and an adapted cost-of-illness evaluation checklist. We performed a narrative synthesis and grouped studies according to reported outcomes and available stratified analyses. In total, 333 reports (330 epidemiological, 3 economic) were included. Most published epidemiological studies (89%) and all economic studies were of good quality. All gray literature reports were from the Ministry of Health or National Environment Agency. Based predominantly on surveillance data, Singapore experienced multiple outbreaks in 2000–2021, attaining peak incidence rate in 2020 (621.1 cases/100,000 person-years). Stratified analyses revealed the highest incidence rates in DENV-2 and DENV-3 serotypes and the 15–44 age group. Among dengue cases, the risk of hospitalization has been highest in the ≥45-year-old age groups while the risks of dengue hemorrhagic fever and death have generally been low (both <1%) for the last decade. Our search yielded limited data on deaths by age, severity, and infection type (primary, secondary, post-secondary). Seroprevalence (dengue immunoglobulin G) increases with age but has remained <50% in the general population. Comprising 21–63% indirect costs, dengue-related total costs were higher in 2010–2020 (SGD 148 million) versus the preceding decade (SGD 58–110 million). Despite abundant passive surveillance data, more stratified and up-to-date data on the epidemiologic and economic burden of dengue are warranted in Singapore to continuously assess prevention and management strategies. Even with its well-regarded vector control program, Singapore has continued to experience dengue outbreaks in recent years. Evaluation of these dengue interventions requires updated information on disease distribution and its costs. Accordingly, we gathered 20 years' worth of data in Singapore from several research databases. Dengue surveillance by Singapore's Ministry of Health, the source of most data, showed that multiple epidemics occurred in 2000–2021, with a peak in 2020, although the prevailing type of dengue virus has shifted over time. Dengue mostly affects the youth (15–24 years of age) and middle-aged adults, but older adults are more frequently hospitalized. Nonetheless, severe disease and death are uncommon among those affected. In our search, we found only limited data on the influence of age, disease severity, or order of infection (first, second, or higher) on dengue deaths. The costs of dengue have increased in the last decade, as costs indirectly related to medical care remain significant cost contributors. Similarly, stratification of costs by age, epidemic versus non-epidemic years and societal or governmental perspective are presently lacking in local literature. More detailed data on the epidemiology and economic burden of dengue could facilitate the design of more tailored interventions to control dengue in Singapore.

The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study

Metabolic Syndromes as Important Comorbidities in Patients of Inherited Retinal Degenerations: Experiences from the Nationwide Health Database and a Large Hospital-Based Cohort

Prevalence, Risk Factors, and Impact of Undiagnosed Visually Significant Cataract: The Singapore Epidemiology of Eye Diseases Study

Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study

Healthcare burden of cognitive impairment: Evidence from a Singapore Chinese health study

Quality of Life and Economic Impacts of Retinitis Pigmentosa on Japanese Patients: A Non-interventional Cross-sectional Study

The epidemiologic and economic burden of dengue in Singapore: A systematic review

Practice Patterns and Challenges in Managing Inherited Retinal Diseases Across Asia-Pacific: A Survey from the APIED Network

Nationwide Prevalence of Inherited Retinal Diseases in the Israeli Population

Estimating Australian Population Utilities for Inherited Retinal Disease Using Time Trade-Off

Burden of Visual Impairment Associated with Eye Diseases: Exploratory Survey of 298 Chinese Patients

The socioeconomic epidemiology of inherited retinal diseases in Portugal

The economics of vision impairment and its leading causes: A systematic review

Direct and indirect costs of osteoarthritis in Singapore: a comparative study among multiethnic Asian patients with osteoarthritis

Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series

Six-year incidence and progression of diabetic retinopathy in Indian adults: the Singapore Indian Eye study

Patient evaluated economic impact of keratoconus in New Zealand

Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains

Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye Study (SiMES)

Visual impairment and blindness caused by retinal diseases: A nationwide register-based study

Estimated Annual Economic Burden of Dry Eye Disease Based on a Multi-Center Analysis in China: A Retrospective Study